Navigating Safety of MS Treatment Strategies for Women of Childbearing Age

Volume 6, Issue 5

Navigating Safety of MS Treatment Strategies for Women of Childbearing Age

In this issue:

The management of multiple sclerosis (MS) can often be challenging, but its complexities increase significantly when family planning and pregnancy are involved. In this issue of eMultipleSclerosis Review, Patricia K. Coyle, MD, Director of the MS Comprehensive Care Center and Professor of Neurology at Stony Brook University, explores critical issues related to the management of MS in women of childbearing age. Dr. Coyle discusses the safety of various disease-modifying therapies during pregnancy, the influence of pregnancy on MS activity, and current perspectives on fertility issues in women with MS.

Learning objective:

Define issues specific to people of childbearing age, such as the safety of various DMTs and the influence of pregnancy on MS activity.

Author:

Patricia K. Coyle, MD, FAAN, FANA

Founder and Director, Stony Brook Multiple Sclerosis Comprehensive Care Center
Professor, Department of Neurology, Renaissance School of Medicine
Stony Brook University
Stony Brook, NY

Guest Faculty Disclosures

Dr. Coyle has indicated that she has received consulting fees from Accordant, Amgen, Bristol-Myers Squibb, Eli Lilly and Company, EMD Serono, GlaxoSmithKline, GE Healthcare Bio-Science, Horizon Therapeutics, LabCorp, Mylan, Novartis AG, and Sanofi Genzyme. She has received grant/research support from Celgene, CorEvitas LLC, Genentech Roche, NINDS, and Sanofi Genzyme.

Unlabeled/Unapproved Uses

Dr. Coyle has indicated that there will be no references to the unlabeled/unapproved uses of any drugs or products.

Program Directors:

Michael Kornberg, MD, PhD

Assistant Professor
Department of Neurology
Johns Hopkins School of Medicine
Baltimore, MD

Pavan Bhargava, MBBS, MD

Assistant Professor
Department of Neurology
Johns Hopkins School of Medicine
Baltimore, MD

Lisa Fox, PA-C, MPAS

Department of Neurology
Johns Hopkins Hospital
Baltimore, MD

Guest Faculty Disclosures:

Unlabeled/Unapproved Uses:

Dr. Coyle has indicated that there will be no references to the unlabeled/unapproved uses of any drugs or products.

Length of activity:

1.0 hour Physicians
1.0 contact hour Nurses

Launch date: November 12, 2024
Expiration date: November 11, 2026

Start Issue